NIH-funded research R21 grant

Transgenesis in a new mammalian model to study adult regeneration

Official title: Transgenesis in a novel mammalian model of adult regeneration

Funded at Seattle Children's Hospital · NIH-11445675 · Data updated 2026-11-12

A medical research project aims to create genetically modified Acomys mice to understand how adult tissues can regenerate and how this could lead to new ways to treat fibrotic diseases.

Quick facts

Grant typeR21 grant
Study typeNIH-funded research
Funding institutionSeattle Children's Hospital
NIH-funded
Lab location1 site (Seattle, United States)
Project startAugust 1, 2026
Project endJuly 31, 2028
Funding year2026
Award (this year)$516,175
NIH project number1R21OD042628-01
Project IDNIH-11445675 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates are adults with fibrotic or regenerative biology conditions, or healthy volunteers contributing samples for comparative studies, depending on future translational steps.

Less likely to help

Direct patient benefits will depend on subsequent clinical translation and are not guaranteed by this early-stage work.

What this research studies

This project uses the spiny mouse (Acomys) as a mammalian model to develop whole-animal transgenic methods, enabling scientists to turn specific genes on or off. The goal is to uncover how certain genes influence regeneration, immunity, and aging, with the aim of identifying targets for anti-fibrosis therapies. Researchers will build new genetic tools and resources in Acomys, coordinating with existing mouse-model knowledge to bridge gaps between models and human disease. The work is foundational and could accelerate drug discovery by clarifying how regeneration pathways relate to fibrosis and chronic inflammation.

Why it matters

Potential benefit: If successful, the work could reveal new genetic targets and strategies to prevent or reverse tissue scarring in humans.

How similar studies have gone: Previous mouse-model transgenesis work informs this project, but applying it to Acomys is novel and exploratory.

Where this research is happening

  • Seattle Children's Hospital
    Seattle, United States
    Active

Researchers

  • Principal investigator: Millen, Kathleen Joyce — Seattle Children's Hospital
  • Study coordinator: Millen, Kathleen Joyce

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.